Please login to the form below

Not currently logged in
Email:
Password:

classic Hodgkin's lymphoma

This page shows the latest classic Hodgkin's lymphoma news and features for those working in and with pharma, biotech and healthcare.

Opdivo edges closer to first haematological cancer indication

Opdivo edges closer to first haematological cancer indication

EMA begins review of BMS' classic Hodgkin’s lymphoma inhibitor treatment. The EU drugs regulator has started its review of Bristol-Myers Squibb's PD-1 inhibitor Opdivo in Hodgkin's ... BMS is seeking approval of Opdivo (nivolumab) for the treatment of

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics